Andrew Paul Lastova, OT in Palisade, CO - Occupational Therapist

Andrew Paul Lastova, OT is a Occupational Therapist based in Palisade, Colorado. Andrew Paul Lastova is licensed to practice in Colorado (license number ) and his current practice location is 151 East 3rd Street, Palisade, Colorado. He can be reached at his office (for appointments etc.) via phone at (970) 464-7500.

NPI number for Andrew Paul Lastova is 1922657139 and his current mailing address is 430 Keener St, Grand Junction, Colorado. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1922657139.

Contact Information

	Andrew Paul Lastova, OT
	151 East 3rd Street, Palisade, CO 81526
	(970) 464-7500
	Not Available

Healthcare Provider's Profile

Full Name	Andrew Paul Lastova
Gender	Male
Speciality	Occupational Therapist
Location	151 East 3rd Street, Palisade, Colorado
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1922657139
Provider Enumeration Date: 09/10/2019
Last Update Date: 09/10/2019

Medical Identifiers

Medical identifiers for Andrew Paul Lastova such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1922657139	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	(Colorado)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Andrew Paul Lastova is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Andrew Paul Lastova, OT 430 Keener St, Grand Junction, CO 81504-4723 Ph: () -	Andrew Paul Lastova, OT 151 East 3rd Street, Palisade, CO 81526 Ph: (970) 464-7500

News Archive

Book on current aspects of dental morphology research

In this publication, an international, multidisciplinary team of researchers addresses important issues on current aspects of dental morphology research from evolutionary, anatomical, clinical and archaeological perspectives.

New modeling study estimates impact of physical distancing in reducing SARS-CoV-2 spread

A new modeling study conducted in a simulated Singapore setting has estimated that a combined approach of physical distancing interventions, comprising quarantine (for infected individuals and their families), school closure, and workplace distancing, is most effective at reducing the number of SARS-CoV-2 cases compared with other intervention scenarios included in the study.

CVRx commences enrollment in study evaluating the Rheos System to treat heart failure

CVRx, Inc. reported the first enrollment of a patient in the HOPE4HF Trial, a study that is evaluating the Rheos System to treat heart failure. The Rheos System uses Baroreflex Activation Therapy® technology, an entirely new non-pharmaceutical approach designed to treat cardiovascular disease. The HOPE4HF Trial is being conducted under an approved investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA).

Enteroviruses may play role in type 1 diabetes

A team of researchers from the Peninsula Medical School in the South West of England, the University of Brighton and the Department of Pathology at Glasgow Royal Infirmary, has found that a common family of viruses (enteroviruses) may play an important role in triggering the development of diabetes, particularly in children.

Andrew Paul Lastova, OT - Occupational Therapist in Palisade, CO